Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Squamous Non-small-cell Lung Cancer × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 45 Carcinoma, Hepatocellular 37 Neoplasms 36 Polycystic Ovary Syndrome 23 Colorectal Neoplasms 23 Stomach Neoplasms 19 Prostatic Neoplasms 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Carcinoma, Non-Small-Cell Lung 15 Recurrence 13 Pancreatic Neoplasms 12 Lymphoma 11 Liver Neoplasms 11 Leukemia, Myeloid, Acute 11 Esophageal Neoplasms 11 Leiomyoma 10 Urinary Bladder Neoplasms 9 Colonic Neoplasms 9 Pain 8 Lung Neoplasms 8 Uterine Cervical Neoplasms 7 Pain, Postoperative 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, Follicular 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Keratosis, Actinic 6 Infertility 6 Neutropenia 5 NSCLC 5

Interventions

Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02996214 2020-02-13

LIPUSU

Nanjing Luye Sike Pharmaceutical Co., Ltd.

Phase 4 Unknown

Squamous Non-small-cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡